GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Debt-to-Asset

Akanda (Akanda) Debt-to-Asset : 0.45 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Akanda Debt-to-Asset?

Akanda's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.50 Mil. Akanda's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.50 Mil. Akanda's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $8.84 Mil. Akanda's debt to asset for the quarter that ended in Dec. 2023 was 0.45.


Akanda Debt-to-Asset Historical Data

The historical data trend for Akanda's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akanda Debt-to-Asset Chart

Akanda Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
- 2.13 1.19 0.10 0.45

Akanda Quarterly Data
Dec19 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.19 0.09 0.10 0.14 0.45

Competitive Comparison of Akanda's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Akanda's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akanda's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akanda's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Akanda's Debt-to-Asset falls into.



Akanda Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Akanda's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Akanda's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akanda  (NAS:AKAN) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Akanda Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Akanda's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Akanda (Akanda) Business Description

Traded in Other Exchanges
Address
1A, 1B Learoyd Road, New Romney, GBR, TN28 8XU
Akanda Corp is a cannabis cultivation, manufacturing and distribution company. The Company has three reportable segments: Cultivation, Distribution and Corporate. Cultivating activities comprise the cultivation segment is made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.